REVIEW

The effect of coagulation factors polymorphisms on abortion

  • Narjes Feizollahi 1 ,
  • Zeinab Deris Zayeri 2 ,
  • Najme Moradi 3 ,
  • Mahvash Zargar 4 ,
  • Hadi Rezaeeyan , 3
Expand
  • 1. Shahid Beheshti University of Medical Sciences and Health Services.Tehran,Iran
  • 2. Golestan Hospital Clinical Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 3. Thalassemia & Hemoglobinopathy Research Center, Research Institute of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 4. Obstetrics & Gynaecology Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Received date: 19 Apr 2018

Accepted date: 21 May 2018

Published date: 31 Jul 2018

Copyright

2018 Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature

Abstract

OBJECTIVE: Recent studies showed coagulation factors play important role in controlling pregnancy duration in addition to controlling homeostasis. Recent studies showed several polymorphisms of coagulation factors genes increase the clot formation and lead to abortion. In this study, we evaluated the polymorphisms of coagulation factors and their effects on the development of the fetus.

MATERIAL and METHODS: Relevant literature was identified by a PubMed search (1988-2017) of English language papers using the terms Abortion, pregnancy woman, coagulation factor and polymorphism.

RESULT: Several polymorphisms of coagulation factors disturb the exchange of food and other materials between the fetus and the mother, and impairs the formation of the placenta during embryonic stages.

DISCUSSION: Evaluation of functional polymorphisms in coagulation factors gene during fetal development can be used as a prognostic factor in the prevention of the abortion.

Cite this article

Narjes Feizollahi , Zeinab Deris Zayeri , Najme Moradi , Mahvash Zargar , Hadi Rezaeeyan . The effect of coagulation factors polymorphisms on abortion[J]. Frontiers in Biology, 2018 , 13(3) : 190 -196 . DOI: 10.1007/s11515-018-1500-8

Authors’ contributions

H.R. conceived the manuscript and revised it; N.F., Z.D., N.M. and M.Z. wrote the manuscript.

Acknowledgments

We wish to thank all our colleagues in Golestan Hospital clinical research development unit, Ahvaz Jundishapur University of Medical Sciences.

Conflict of interest

Authors declare that they have no conflict of interest.
1
Aarabi M, Memariani T, Arefi S, Aarabi M, Hantoosh Zadeh S, Akhondi M A, Modarressi M H (2011). Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion. J Matern Fetal Neonatal Med, 24(3): 545–548

DOI PMID

2
Abbate R, Sofi F, Gensini F, Fatini C, Sticchi E, Fedi S (2002). Thrombophilias as risk factors for disorders of pregnancy and fetal damage. Pathophysiol Haemost Thromb, 32(5-6): 318–321

DOI PMID

3
Al-Azzawie H F, Sabri S (2014). C677T and A1298C polymorphisms of Methylenetetrahydrofolate Reductase Gene in Iraqi Patients with Recurrent Abortion. Int J, 2(6): 227–234

4
Aleman M M, Byrnes J R, Wang J G, Tran R, Lam W A, Di Paola J, Mackman N, Degen J L, Flick M J, Wolberg A S (2014). Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest, 124(8): 3590–3600

DOI PMID

5
Anokhin B A, Stribinskis V, Dean W L, Maurer M C (2017). Activation of factor XIII is accompanied by a change in oligomerization state. FEBS J, 284(22): 3849–3861

DOI PMID

6
Antza C, Cifkova R, Kotsis V (2017). Hypertensive complications of pregnancy: A clinical overview. Metabolism: S0026-0495(17)30323-2

DOI PMID

7
Avila-Vergara M, Felipe de Jesús Peraza-Garay, Noemí Meraz-Cruz, Cesar Hernandez-Guerrero, Berenice Palacios-Gonzalez, Felipe Vadillo-Ortega (2018). Association of Intron-2 Variable Numbers of an 86-bp Tandem Repeat-Polymorphisms of Interleukin-1 Receptor Antagonist Gene and Idiopathic Recurrent Spontaneous Abortion. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 70(2): 96–102

8
Badenhop R F, Wang X L, Wilcken D E (1995). Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation, 91(6): 1655–1658

DOI PMID

9
Bailey L B, Gregory J F 3rd (1999). Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr, 129(5): 919–922

DOI PMID

10
Barlik M, Seremak-Mrozikiewicz A, Drews K, Klejewski A, Kurzawińska G, Łowicki Z, Wolski H (2016). Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage. Ginekol Pol, 87(7): 504–509

DOI PMID

11
Ben-Ami I, Fuchs N, Schneider D, Pansky M, Halperin R, the BEN‐AMI (2012). Coagulopathy associated with dilation and evacuation for second-trimester abortion. Acta Obstet Gynecol Scand, 91(1): 10–15

DOI PMID

12
Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler C J (2003). Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod, 18(11): 2473–2477

DOI PMID

13
Cardenas J C, Matijevic N, Baer L A, Holcomb J B, Cotton B A, Wade C E (2014). Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock, 41(6): 514–521

DOI PMID

14
Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, Girolami A, Bernardi F (2000). Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood, 96(4): 1443–1448

PMID

15
Chen Z, Xu F, Wei Y, Liu F, Qi H (2012). Angiotensin converting enzyme insertion/deletion polymorphism and risk of pregnancy hypertensive disorders: a meta-analysis. J Renin Angiotensin Aldosterone Syst, 13(1): 184–195

DOI PMID

16
Chodirker B N, Dawson A J (2011). Recurrent miscarriage. N Engl J Med, 364(8): 783–784

DOI PMID

17
Coolman M, de Groot C J M, Steegers E A P, Geurts-Moespot A, Thomas C M G, Steegers-Theunissen R P M, Sweep F C G J (2006). Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol, 128(1-2): 22–28

DOI PMID

18
D’Elia P Q, dos Santos A A, Bianco B, Barbosa C P, Christofolini D M, Aoki T (2014). MTHFR polymorphisms C677T and A1298C and associations with IVF outcomes in Brazilian women. Reprod Biomed Online, 28(6): 733–738

DOI PMID

19
Djurovic J, Stojkovic O, Todorovic J, Brajic A, Stankovic S, Obradovic S, Stamenkovic G (2017). Genetics of suspected thrombophilia in Serbian females with infertility, including three cases, homozygous for FII 20210A or FV 1691A mutations. Hum Fertil (Camb), 20(2): 132–139

DOI PMID

20
Dorgalaleh A, Rashidpanah J (2016). Blood coagulation factor XIII and factor XIII deficiency. Blood Rev, 30(6): 461–475

DOI PMID

21
Egerup P, Kolte A M, Larsen E C, Krog M, Nielsen H S, Christiansen O B (2016). Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses? Hum Reprod, 31(11): 2428–2434

DOI PMID

22
ElDanasori N, Abulata N, Shaheen I A, ElGendy A M, El-Khayat W (2017). Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion. Clin Appl Thromb Hemost, 24 (3): 532-535

PMID

23
Elkin A C, Higham J (2000). Folic acid supplements are more effective than increased dietary folate intake in elevating serum folate levels. BJOG, 107(2): 285–289

DOI PMID

24
Festa A, D’Agostino R Jr, Rich S S, Jenny N S, Tracy R P, Haffner S M (2003). Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation, 107(19): 2422–2427

DOI PMID

25
Ford J G, Li Y, O’Sullivan M M, Demopoulos R, Garte S, Taioli E, Brandt-Rauf P W (2000). Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis, 21(11): 1971–1975

DOI PMID

26
Franssen M T, Nico J Leschot, Patrick M M Bossuyt, Alida C Knegt, Klasien B J Gerssen-Schoorl, Cokkie H Wouters, Kerstin B M Hansson, Ron Hochstenbach, Kamlesh Madan, Fulco van der Veen, Mariette Goddijn (2005). Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ, 331(7509): 137–141

27
Garlantézec R, Chevrier C, Coiffec I, Celebi C, Cordier S (2012). Combined effect of prenatal solvent exposure and GSTT1 or GSTM1 polymorphisms in the risk of birth defects. Birth Defects Res A Clin Mol Teratol, 94(6): 481–485

DOI PMID

28
Glueck C J, Wang P, Goldenberg N, Sieve L (2004). Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin. Clin Appl Thromb Hemost, 10(4): 323–334

DOI PMID

29
Guerra-Shinohara E M, Bertinato J F, Tosin Bueno C, Cordeiro da Silva K, Burlacchini de Carvalho M H, Pulcineli Vieira Francisco R, Zugaib M, Cerda A, Morelli V M (2012). Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss. Thromb Haemost, 108(4): 693–700

PMID

30
Hayashi Y, Sasaki H, Suzuki S, Nishiyama T, Kitaori T, Mizutani E, Suzumori N, Sugiura-Ogasawara M (2013). Genotyping analyses for polymorphisms of ANXA5 gene in patients with recurrent pregnancy loss. Fertil Steril, 100(4): 1018–1024

DOI PMID

31
James A H (2009). Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol, 29(3): 326–331

DOI PMID

32
Jeddi-Tehrani M, Torabi R, Mohammadzadeh A, Arefi S, Keramatipour M, Zeraati H, Zarnani A H, Akhondi M M, Mahmoudian J, Mahmoudi A R, Zarei S (2010). Investigating association of three polymorphisms of coagulation factor XIII and recurrent pregnancy loss. Am J Reprod Immunol, 64(3): 212–217

DOI PMID

33
Kamimoto Y, Wada H, Ikejiri M, Nakatani K, Sugiyama T, Osato K, Murabayashi N, Habe K, Mizutani H, Matsumoto T, Ohishi K, Ikeda T (2017). Hypofibrinogenemia and the a-Fibrinogen Thr312Ala polymorphism may be risk factors for early pregnancy loss. Clin Appl Thromb Hemost, 23(1): 52–57

DOI PMID

34
Karatas A, Eroz R, Albayrak M, Ozlu T, Cakmak B, Keskin F (2014). Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage. Afr Health Sci, 14(1): 216–222

DOI PMID

35
Karimlo F K, Mashayekhi F, Sorouri Z Z, Bahador M H, Salehi Z (2015). Association of GSTM1 and GSTT1 gene polymorphisms and in-vitro fertilisation outcome in a population in northern Iran. J Obstet Gynaecol, 35(1): 46–48

DOI PMID

36
Kim S Y, Park S Y, Choi J W, Kim D J, Lee S Y, Lim J H, Han J Y, Ryu H M, Kim M H (2011). Association between MTHFR 1298A>C polymorphism and spontaneous abortion with fetal chromosomal aneuploidy. Am J Reprod Immunol, 66(4): 252–258

DOI PMID

37
Kohler H P (2001). Role of blood coagulation factor XIII in vascular diseases. Swiss Med Wkly, 131(3-4): 31–34

PMID

38
Kotze M J, La Grange C, Mansvelt E (2005). Genetics in family practice: rapid thrombophilia genetic test facilitates improved prenatal care for mother and child. S Afr Fam Pract, 47(7): 50–51

DOI

39
Kuhli C, Lüchtenberg M, Scharrer I, Hattenbach L O (2005). Massive subhyaloidal hemorrhage associated with severe PAI-1 deficiency. Graefes Arch Clin Exp Ophthalmol, 243(10): 963–966

DOI PMID

40
Kupferminc M J (2003). Thrombophilia and pregnancy. Reprod Biol Endocrinol, 1(1): 111

DOI PMID

41
Kurzawińska G, Seremak-Mrozikiewicz A, Drews K, Barlik M, Mrozikiewicz P M (2009). (Genetic conditioned changes in activity of 5,10-methylenetetrahydrofolate reductase (MTHFR) and recurrent miscarriages). Ginekol Pol, 80(10): 762–767

PMID

42
López-Jiménez J, Porras-Dorantes Á, Juárez-Vázquez C I, García-Ortiz J E, Fuentes-Chávez C A, Lara-Navarro I J, Jaloma-Cruz A R (2016). Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss. Genet Mol Res, 15(4)

DOI

43
Luo Y, Wang C, Tu H (2014). Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome. Mol Med Rep, 9(3): 894–898

DOI PMID

44
Lyall F, Bulmer J N, Duffie E, Cousins F, Theriault A, Robson S C (2001). Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol, 158(5): 1713–1721

DOI PMID

45
MacCallum P, Bowles L, Keeling D (2014). Diagnosis and management of heritable thrombophilias. BMJ, 349(7967): g4387

46
Masini S, Ticconi C, Gravina P, Tomassini M, Pietropolli A, Forte V, Federici G, Piccione E, Bernardini S (2009). Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss. Fertil Steril, 92(2): 694–702

DOI PMID

47
Matsumoto T, Nogami K, Shima M (2013). Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost, 110(4): 761–768

DOI PMID

48
Medicine P C A S R, and the Practice Committee of American Society for Reproductive Medicine (2013). Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril, 99(1): 63

DOI PMID

49
Middeldorp S (2007). Pregnancy failure and heritable thrombophilia. in Seminars in hematology. Elsevier

50
Mowla K, Rajaei E, Jalali M T, Zayeri Z D (2018). Threatening biomarkers in lupus pregnancy: Biochemistry and genetic challenges. Front Biol: 13 (1) : 1–8

51
Mtiraoui N, Borgi L, Gris J C, Almawi W Y, Mahjoub T (2004). Factor V Leiden, prothrombin G20210A and antibodies against phospholipids in recurrent spontaneous abortion. J Thromb Haemost, 2(8): 1482–1484

DOI PMID

52
Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan R R, Gris J C, Almawi W Y, Mahjoub T (2005). Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol, 119(2): 164–170

DOI PMID

53
Muszbek L, Katona É ( 2016). Diagnosis and management of congenital and acquired FXIII deficiencies. in Seminars in thrombosis and hemostasis. Thieme Medical Publishers

54
Naderi M, Dorgalaleh A, Tabibian Sh, Alizadeh Sh, Eshghi P, Solaimani G (2013). Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol, 3(4): 164–172

PMID

55
Pereza N, Ostojić S, Kapović M, Peterlin B (2017). Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. Fertil Steril, 107(1): 150–159

56
Pickering W, Marriott K, Regan L (2001). G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Hemost, 7(1): 25–28

DOI PMID

57
Prat M, Morales-Indiano C, Jimenez C, Mas V, Besses C, Checa M A, Carreras R (2014). “20209C-T” a variant mutation of prothrombin gene mutation in a patient with recurrent pregnancy loss. Ann Clin Lab Sci, 44(3): 334–336

PMID

58
Qublan H S, Eid S S, Ababneh H A, Amarin Z O, Smadi A Z, Al-Khafaji F F, Khader Y S (2006). Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod, 21(10): 2694–2698

DOI PMID

59
Rezaeeyan H, Jaseb K, Alghasi A, Asnafi A A, Saki N (2017). Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. Blood Coagul Fibrinolysis, 28(8): 617–622

DOI PMID

60
Rijken D C, Lijnen H R (2009). New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost, 7(1): 4–13

DOI PMID

61
Sata F, Yamada H, Kondo T, Gong Y, Tozaki S, Kobashi G, Kato EH, Fujimoto S, Kishi R (2003). Glutathione S‐transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss. MHR: Basic science of reproductive medicine, 9(3): 165–169

62
Shi Q, Hu M, Luo M, Liu Q, Jiang F, Zhang Y, Wang S, Yan C, Weng Y (2011). Reduced expression of Mad2 and Bub1 proteins is associated with spontaneous miscarriages. Mol Hum Reprod, 17(1): 14–21

DOI PMID

63
Simcox L E, Ormesher L, Tower C, Greer I A (2015). Thrombophilia and pregnancy complications. Int J Mol Sci, 16(12): 28418–28428

DOI PMID

64
Su M T, Lin S H, Chen Y C, Kuo P L (2013). Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Thromb Haemost, 109(1): 8–15

PMID

65
Tulandi, T. and Al-FozanH., Definition and etiology of recurrent pregnancy loss. Up To Date Last updated, 2011. 16.

66
Tusskorn O, Khunluck T, Prawan A, Senggunprai L, Kukongviriyapan U, Kukongviriyapan V (2018). Suppression of glutathione S-transferases potentiates the cytotoxic effect of phenethyl isothiocyanate in cholangiocarcinoma cells. Naunyn Schmiedebergs Arch Pharmacol, 391(6): 657–667

PMID

67
Van der Put, N., van der Molen E F, Kluijtmans L A, Heil S G, Trijbels J M, Eskes T K, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom H J (1997). Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM, 90(8): 511–517

68
Vívenes-de Lugo M, Alvaro R L, Belsy G, Dinorah C D G (2008). Ethnic/geographic variation of the val34leu polymorphism of coagulation factor XIII and its distribution in American admixed populations. Internet J Biol Anthropol, 2: 1

69
Vora S, Shetty S, Khare M, Ghosh K (2009). Placental histomorphology in unexplained foetal loss with thrombophilia. Indian J Med Res, 129(2): 144–149

PMID

70
Walton B L, Byrnes J R, Wolberg A S (2015). Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost, 13(Suppl 1): S208–S215

DOI PMID

71
Wang H Y, Qiao J, Sun X X, Wang S Y, Liang X Y, Sun Y, Liu F H (2017). Epidemiological Survey and Risk Factor Analysis of Recurrent Spontaneous Miscarriages in Infertile Women at Large Infertility Centers. Chin Med J (Engl), 130(17): 2056–2062

DOI PMID

72
Wolski H, Barlik M, Drews K, Klejewski A, Kurzawińska G, Ożarowski M, Łowicki Z, Seremak-Mrozikiewicz A (2017). Contribution of inherited thrombophilia to recurrent miscarriage in the Polish population. Ginekol Pol, 88(7): 385–392

DOI PMID

Outlines

/